An Industry-Driven Roadmap for Manufacturing in Regenerative Medicine

Stem Cells Translational Medicine
Joshua HunsbergerAnthony Atala

Abstract

Regenerative medicine is poised to become a significant industry within the medical field. As such, the development of strategies and technologies for standardized and automated regenerative medicine clinical manufacturing has become a priority. An industry-driven roadmap toward industrial scale clinical manufacturing was developed over a 3-year period by a consortium of companies with significant investment in the field of regenerative medicine. Additionally, this same group identified critical roadblocks that stand in the way of advanced, large-scale regenerative medicine clinical manufacturing. This perspective article details efforts to reach a consensus among industry stakeholders on the shortest pathway for providing access to regenerative medicine therapies for those in need, both within the United States and around the world. Stem Cells Translational Medicine 2018;7:564-568.

References

Jan 31, 2006·IEE Proceedings. Nanobiotechnology·D J Williams, I M Sebastine
Dec 24, 2010·Regenerative Medicine·Ui-Lyong LeePill-Hoon Choung
Aug 20, 2011·British Medical Bulletin·Elizabeth RatcliffeDavid J Williams
Oct 26, 2011·Regenerative Medicine·David J Williams
Apr 18, 2014·Science Translational Medicine·Ivan MartinDavid F Williams
Jan 13, 2015·Stem Cells Translational Medicine·Joshua HunsbergerAnthony Atala
Nov 2, 2016·ClinicoEconomics and Outcomes Research : CEOR·Matt MooreJohn A Rizzo
Apr 7, 2017·Journal of Tissue Engineering and Regenerative Medicine·Chee Keong KwokFrank Edenhofer

❮ Previous
Next ❯

Citations

Feb 8, 2020·Biofabrication·Wei SunIbrahim T Ozbolat
Aug 9, 2020·Frontiers in Bioengineering and Biotechnology·Meletios-Nikolaos DoulgkeroglouDimitrios I Zeugolis
Jan 28, 2020·The International Journal, Advanced Manufacturing Technology·Maryam ShariatzadehDavid J Williams
Mar 4, 2021·American Journal of Physiology. Cell Physiology·Dimitrios I Zeugolis
Jul 18, 2020·International Journal of Biological Macromolecules·Andrea De PieriDimitrios I Zeugolis
Mar 31, 2021·Npj Regenerative Medicine·Andrea De PieriDimitrios I Zeugolis
Jun 19, 2020·ACS Biomaterials Science & Engineering·Sreedevi RamanDavid A Brafman

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensors
imaging techniques

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Connecticut Medicine
Michael F Saffir
Nursing Standard
Erin Dean
Harvard Dental Alumni Bulletin
H B SPRAGUE
© 2022 Meta ULC. All rights reserved